We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.07B
AUM Growth
+$304M
Cap. Flow
+$228M
Cap. Flow %
11.06%
Top 10 Hldgs %
26.72%
Holding
186
New
38
Increased
42
Reduced
61
Closed
43

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$29.1M
2
FUN icon
Cedar Fair
FUN
+$27.5M
3
DV icon
DoubleVerify
DV
+$26.8M
4
CNMD icon
CONMED
CNMD
+$21.8M
5
XRAY icon
Dentsply Sirona
XRAY
+$20.7M

Top Sells

Rank Stock Value
1
AAP icon
Advance Auto Parts
AAP
+$29.3M
2
NGD
New Gold Inc
NGD
+$20.9M
3
WBD icon
Warner Bros
WBD
+$20.7M
4
VRNT
Verint Systems
VRNT
+$19.9M
5
M icon
Macy's
M
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 20.05%
2 Healthcare 18.45%
3 Consumer Discretionary 15.14%
4 Materials 10.18%
5 Industrials 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DKNG icon
151
DraftKings
DKNG
$12B
– –
-84,935
Closed -$3.64M
FHI icon
152
Federated Hermes
FHI
$4.71B
– –
-295,097
Closed -$13.1M
FIVE icon
153
Five Below
FIVE
$13B
– –
-110,360
Closed -$14.5M
FLGT icon
154
Fulgent Genetics
FLGT
$524M
– –
-31,125
Closed -$619K
FLYW icon
155
Flywire
FLYW
$2.11B
– –
-632,576
Closed -$7.4M
GEHC icon
156
GE HealthCare
GEHC
$32.9B
– –
-96,697
Closed -$7.16M
HALO icon
157
Halozyme
HALO
$12.2B
– –
-77,793
Closed -$4.05M
IAS
158
DELISTED
Integral Ad Science
IAS
– –
-1,580,066
Closed -$13.1M
JOUT icon
159
Johnson Outdoors
JOUT
$501M
– –
-29,284
Closed -$886K
KOP icon
160
Koppers
KOP
$956M
– –
-34,118
Closed -$1.1M
KSS icon
161
Kohl's
KSS
$2.16B
– –
-475,299
Closed -$4.03M
KWR icon
162
Quaker Houghton
KWR
$2.96B
– –
-40,464
Closed -$4.53M
LASR icon
163
nLIGHT
LASR
$2.88B
– –
-165,269
Closed -$3.25M
LDOS icon
164
Leidos
LDOS
$17.5B
– –
-29,085
Closed -$4.59M
MD icon
165
Pediatrix Medical
MD
$2.12B
– –
-285,906
Closed -$4.1M
MHK icon
166
Mohawk Industries
MHK
$9.19B
– –
-55,485
Closed -$5.82M
MPC icon
167
Marathon Petroleum
MPC
$90B
– –
-48,506
Closed -$8.06M
MTCH icon
168
Match Group
MTCH
$8.43B
– –
-381,866
Closed -$11.8M
NABL icon
169
N-able
NABL
$605M
– –
-510,155
Closed -$4.13M
NEM icon
170
Newmont
NEM
$124B
– –
-194,124
Closed -$11.3M
NEOG icon
171
Neogen
NEOG
$2.49B
– –
-490,008
Closed -$2.34M
NGD
172
DELISTED
New Gold Inc
NGD
– –
-4,227,089
Closed -$20.9M
OPEN icon
173
Opendoor
OPEN
$3.38B
– –
-5,638,365
Closed -$2.91M
PETS icon
174
PetMed Express
PETS
$42.1M
– –
-97,934
Closed -$325K
PHIN icon
175
Phinia Inc
PHIN
$2.7B
– –
-229,254
Closed -$10.2M
4 5 6
7
8

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Invenomic Capital Management held 186 positions worth $2.07B, up 17% from $1.76B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Invenomic Capital Management deployed $228M of net new capital in Q3 2025, opening 38 new positions and adding to 42 existing holdings. Its largest new stake was Cedar Fair: 1,034,288 shares worth $23.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Warner Bros, an estimated $20.7M trimmed.

  • Invenomic Capital Management's largest Q3 2025 buy was Cedar Fair: 1,034,288 shares worth $23.5M.
  • Invenomic Capital Management added most to Haemonetics in Q3 2025, an estimated $29.1M increase.
  • Invenomic Capital Management's biggest Q3 2025 reduction was Warner Bros, cutting an estimated $20.7M.
  • Invenomic Capital Management fully exited Advance Auto Parts in Q3 2025, selling an estimated $29.3M.
  • Invenomic Capital Management's ten largest holdings make up 27% of its $2.07B portfolio in Q3 2025.
  • Invenomic Capital Management opened 38 new positions and closed 43 in Q3 2025.
  • Invenomic Capital Management's portfolio value rose 17% quarter-over-quarter to $2.07B.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.